Company intelligence / Profile preview

Dragenopharm

Tittmoning, Bavaria, Germanyaenova-group.com ↗
Ownership
Private
Employees
~570
Development stage
Other
01

Overview

Dragenopharm (officially Dragenopharm Apotheker Püschl GmbH) is a German contract development and manufacturing organization (CDMO) specializing in solid dosage forms, including tablets, film-coated tablets, sugar-coated tablets, and hard shell capsules. Founded in 1949 and headquartered in Tittmoning, Germany, the company merged with Swiss Caps in 2008 to form the Aenova Group, one of the world's leading pharmaceutical CDMOs. Dragenopharm operates as a key high-volume manufacturing site within the Aenova network, producing prescription drugs, over-the-counter (OTC) medicines, and dietary supplements. Its state-of-the-art facility in Tittmoning is one of Europe's largest production plants for oral solids, with capabilities extending to controlled-release products, narcotics, and packaging services.

Modalities
Small moleculePeptides
Industry
Contract Manufacturing Organization
02

Partnerships

Boehringer Ingelheim

Beyond the preview

Go deeper on Dragenopharm.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dragenopharm.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call